The impact of Global Fund investment in fighting malaria
by Malaria Consortium staff
Approx reading time:
The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) is a critical financing mechanism that has invested more than US$55 billion over the last 20 years to fund health programmes in countries with the highest burden of HIV, TB and malaria, and the lowest economic capacity to tackle these diseases.
Most of the Global Fund’s financing comes from public resources – national governments of more than 80 countries who have made or have pledged contributions. Recipient countries are able to develop proposals for how Global Fund support can be used over the grant cycle, allowing grants to be strongly aligned to each country’s needs and priorities. This financing mechanism is unique in its scale, geographic reach and its potential to tackle inequities, providing access to services for those who may be biologically vulnerable, marginalised or living in remote locations. The long-term (three-year) grant cycle also brings longer-term predictability to financing, helping to establish equity in access to health services through well-functioning, resilient and sustainable systems.
As we approach the Global Fund’s seventh replenishment – with the aim to raise at least US$18 billion for the 2023-25 cycle and ambitions to cut malaria deaths by 64 percent – we take a look at the impact the Global Fund has had on fighting malaria across Africa and Asia, and the critical next steps needed to meet the Global Technical Strategy for Malaria (2016-2030) target of reducing malaria case incidence and mortality by 75 percent by 2025.